.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The CLASSIC randomized trial was an important step in defining the role of laparoscopic-assisted surgery for colorectal cancer. The study compared laparoscopic-assisted surgery with conventional open surgery and evaluated short-term surgical outcomes as well as longer-term cancer outcomes. Although laparoscopic procedures can be technically demanding, the trial showed that appropriately performed minimally invasive colorectal surgery could achieve acceptable oncological results while offering the familiar recovery advantages of a less invasive approach. The significance of CLASSIC lies in its contribution to the transition from proof-of-concept laparoscopy to routine colorectal practice. It helped demonstrate that conversion to open surgery, postoperative morbidity, recurrence and survival could be assessed within a rigorous randomized framework rather than relying solely on single-centre experience. The trial also emphasized the importance of surgeon training and patient selection as minimally invasive surgery expanded. For today's surgeon, CLASSIC is best viewed as one of the foundational trials supporting laparoscopic colorectal surgery. Its results helped establish that the question is not simply whether laparoscopy is feasible, but whether it can reproduce sound oncological surgery with acceptable perioperative outcomes. Modern enhanced-recovery pathways and better technology have since further strengthened the practical value of minimally invasive colorectal surgery.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The CLASSIC randomized trial was an important step in defining the role of laparoscopic-assisted surgery for colorectal cancer. The study compared laparoscopic-assisted surgery with conventional open surgery and evaluated short-term surgical outcomes as well as longer-term cancer outcomes. Although laparoscopic procedures can be technically demanding, the trial showed that appropriately performed minimally invasive colorectal surgery could achieve acceptable oncological results while offering the familiar recovery advantages of a less invasive approach. The significance of CLASSIC lies in its contribution to the transition from proof-of-concept laparoscopy to routine colorectal practice. It helped demonstrate that conversion to open surgery, postoperative morbidity, recurrence and survival could be assessed within a rigorous randomized framework rather than relying solely on single-centre experience. The trial also emphasized the importance of surgeon training and patient selection as minimally invasive surgery expanded. For today's surgeon, CLASSIC is best viewed as one of the foundational trials supporting laparoscopic colorectal surgery. Its results helped establish that the question is not simply whether laparoscopy is feasible, but whether it can reproduce sound oncological surgery with acceptable perioperative outcomes. Modern enhanced-recovery pathways and better technology have since further strengthened the practical value of minimally invasive colorectal surgery.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
